Autopsy report · NCT00936832

Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by Surgery

Cause of deathFutility Automatic label, confidence 0.9, unverified. How labels are made.

“because the sunitinib showed futility in anotehr trial”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 2
Sponsor: Federation Francophone de Cancerologie Digestive
Sponsor type: University, hospital or other
Conditions: Colorectal Cancer; Metastatic Cancer
Interventions: FOLFIRI regimen; fluorouracil; irinotecan hydrochloride; leucovorin calcium; sunitinib malate; laboratory biomarker analysis
Participants: 0
Sites: 1
Countries: France

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.